HI
VOR icon

Harbour Investments’s Vor Biopharma VOR Stock Holding History

Harbour Investments’s Portfolio VOR Stock Details VOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-10
Closed -$140 – 3582
2024
Q3 		$140 Hold
10
– – ﹤0.01% 3299
2024
Q2 		$200 Hold
10
– – ﹤0.01% 3162
2024
Q1 		$474 Buy
+10
New +$439 ﹤0.01% 3029

Other funds holding VOR

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JJ
Johnson & Johnson New Brunswick, New Jersey $652M AUM 198.07% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Harbour Investments's VOR Position: Q4 2024 in Review

Harbour Investments sold out of Vor Biopharma (VOR) in Q4 2024, closing a stake of 10 shares — an estimated $140 sold.

Harbour Investments first reported a position in VOR in Q1 2024 and held it in 3 quarters. The position peaked at $474 in Q1 2024. 50 funds tracked by Wall St. Rank hold VOR as of Q4 2024.

  • Harbour Investments reported no remaining Vor Biopharma position as of Q4 2024 after selling out during the quarter.
  • Harbour Investments sold 10 Vor Biopharma shares in Q4 2024, an estimated $140.
  • Harbour Investments first reported a position in Vor Biopharma in Q1 2024 and held it in 3 quarters.
  • Harbour Investments's Vor Biopharma position peaked at $474 in Q1 2024.
  • 50 funds tracked by Wall St. Rank held Vor Biopharma as of Q4 2024.

Based on Harbour Investments's 13F filing for Q4 2024, filed 10 Feb 2025.